Clinical Trials of Multivalent Opioid Vaccine Components
(Healthy individuals who use heroin or other opioids)
| Sponsor | National Institute on Drug Abuse |
| Principal Investigator | Sandra Comer, PhD |
| Enrolling | Male and Female Patients |
| Study Length | 46 Weeks |
| IRB Number | 7712 |
| U.S. Govt. ID | NCT04458545 |
| Contact | 646-774-6243 |
Additional Study Information:
Physically dependent, healthy individuals who use opioids needed for an outpatient research study at the New York State Psychiatric Institute. Earn up to $6,000 for your participation.
Screening Procedures Include:
- 3-5 Screening visits to determine eligibility ($75 per visit)
If Eligible, Study Procedures Include:
- Regular study visits for 21 weeks
- Continued study visits from weeks 21-42 (every 4-6 weeks)
- Regular assessment of physical health (ECG, vitals, bloodwork)
- Psychiatric Assessments
- Questions about side effects and new medications